We have mentioned that CRGs modulate immune checkpoint expression in tumors [102, 132, 133], DSF induces upregulation of PD-L1 expression in NSCLC [148], and copper chelators promote PD-L1 ubiquitination and degradation [192]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.